| The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus 2004 · 3 mg copper and placebo fish oil · patients with systemic lupus erythematosus | 3 mg | 24 weeks | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 2 mg | 8 years | — |
| Therapeutic evaluation of zinc and copper supplementation in acute diarrhea in children: double blind randomized trial 2005 · zinc and copper supplementation · Children aged 6 months to 59 months with acute diarrhea in an urban hospital | 5 mg | — | 102 |
| Determination of an acute no-observed-adverse-effect level (NOAEL) for copper in water 2001 · 2 mg Cu/L group · Apparently healthy individuals; age and sex not specified | 57.1 mcg | 5 weeks | — |
| Determination of an acute no-observed-adverse-effect level (NOAEL) for copper in water 2001 · 4 mg Cu/L group · Apparently healthy individuals; age and sex not specified | 114 mcg | 5 weeks | — |
| Determination of an acute no-observed-adverse-effect level (NOAEL) for copper in water 2001 · 6 mg Cu/L group · Apparently healthy individuals; age and sex not specified | 171 mcg | 5 weeks | — |
| Determination of an acute no-observed-adverse-effect level (NOAEL) for copper in water 2001 · 8 mg Cu/L group · Apparently healthy individuals; age and sex not specified | 229 mcg | 5 weeks | — |
| Effects of fortified milk on morbidity in young children in north India: community based, randomised, double masked placebo controlled trial 2007 · fortified milk · Children aged 1–3 years in a peri-urban settlement in north India | 270 mcg | 1 year | 316 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 2 mg | 8 years | — |
| Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren 2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified | 2 mg | 335 days | — |
| Zinc and copper supplementation in acute diarrhea in children: a double-blind randomized controlled trial 2009 · zinc and copper (Zn+Cu) arm · Children aged 6–59 months with acute watery or bloody diarrhea | 0.2 mg/kg | 2 weeks | 273 |
| The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus 2004 · 3 g MaxEPA and 3 mg copper · patients with systemic lupus erythematosus | 3 mg | 24 weeks | — |
| Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months 2014 · zinc, iron, and copper supplement · Infants aged 6–18 months | 500 mcg | 1 year | — |
| Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6-18 months 2014 · iron and copper supplement · Infants aged 6–18 months | 500 mcg | 1 year | — |
| Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women 2011 · 600 mg Ca plus 2 mg Cu and 12 mg Zn · Healthy postmenopausal women aged 51–80 years | 2 mg | 2 years | 112 |
| Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals 1994 · trace minerals only · Healthy postmenopausal women, mean age 66 years | 2.5 mg | 2 years | — |
| Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women 2005 · 3 mg Cu/d · Healthy young women, mean age 24 years | 3 mg | 4 weeks | 16 |
| Zinc supplementation has no effect on lipoprotein metabolism, hemostasis, and putative indices of copper status in healthy men 2003 · Group 1 — copper supplementation · Healthy men; age range not reported | 3 mg | 8 weeks | — |
| Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial 2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering | 270 mcg | 1 year | 316 |
| Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year 2008 · treated AMD (T-AMD) group · Patients with nonadvanced age-related macular degeneration; mean age 69.4 years | 1 mg | 1 year | 15 |
| The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise 2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day | 1 mg | 4 weeks | 10 |
| Copper supplementation of adult men: effects on blood copper enzyme activities and indicators of cardiovascular disease risk 1997 · copper · Adult men with moderately high plasma cholesterol | 2 mg | 4 weeks | 20 |
| Low dietary copper increases fecal free radical production, fecal water alkaline phosphatase activity and cytotoxicity in healthy men 2003 · Basal diet supplemented with 2 mg Cu/d · Healthy, free-living, nonsmoking men aged 21–52 years | 2 mg | 6 weeks | 17 |
| No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status 2001 · 3 mg Cu/day · Healthy young adult females aged 20–28 years | 3 mg | 4 weeks | 16 |
| A pilot study of copper supplementation effects on plasma F2alpha isoprostanes and urinary collagen crosslinks in young adult women 2010 · copper supplementation · Young adult women; 8 female university students | 2 mg | 8 weeks | 8 |
| The effects of chromium and copper supplementation on mitogen-stimulated T cell proliferation in hypercholesterolaemic postmenopausal women 2002 · 3.0 mg Cu · Hypercholesterolaemic postmenopausal women | 3 mg | 12 weeks | — |
| A randomized trial of copper supplementation effects on blood copper enzyme activities and parameters related to cardiovascular health 2012 · copper supplementation · Healthy middle-aged adults with moderately high cholesterol | 2 mg | 8 weeks | — |
| Effect of copper supplementation on indices of copper status and certain CVD risk markers in young healthy women 2005 · 6 mg Cu/d · Healthy young women, mean age 24 years | 6 mg | 4 weeks | 16 |
| Adaptive responses in men fed low- and high-copper diets 2003 · Moderate-Cu diet · Healthy men aged 20–59 years | 1.6 mg | 8 weeks | 12 |
| Adaptive responses in men fed low- and high-copper diets 2003 · High-Cu diet · Healthy men aged 20–59 years | 6 mg | 8 weeks | 12 |
| [Vitrum osteomag in prevention of osteoporosis in postmenopausal women: results of the comparative open multicenter trial] 2004 · Group 1: Vitrum Osteomag · Postmenopausal women with osteopenia; age range not reported | 2 mg | 1 year | 125 |
| Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals 1994 · calcium plus trace minerals · Healthy postmenopausal women, mean age 66 years | 2.5 mg | 2 years | — |
| No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status 2001 · 6 mg Cu/day · Healthy young adult females aged 20–28 years | 6 mg | 4 weeks | 16 |
| The effects of chromium and copper supplementation on mitogen-stimulated T cell proliferation in hypercholesterolaemic postmenopausal women 2002 · 200 microg Cr and 3.0 mg Cu · Hypercholesterolaemic postmenopausal women | 3 mg | 12 weeks | — |
| Adaptive responses in men fed low- and high-copper diets 2003 · Low-Cu diet · Healthy men aged 20–59 years | 700 mcg | 8 weeks | 12 |
| The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7 2002 · zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration | 2 mg | 5 years | — |
| Zinc supplementation inhibits complement activation in age-related macular degeneration 2014 · Zinc and copper supplement · Adults with age-related macular degeneration; mean age 73.9 years | 1 mg | 90 days | 72 |
| Effects of tribasic copper chloride versus copper sulfate provided in corn-and molasses-based supplements on forage intake and copper status of beef heifers 2007 · Experiment 1: 100 mg of Cu/d from CuSO(4) · Growing, non-pregnant crossbred beef heifers; 8 per arm | 100 mg | 90 days | 8 |
| Effects of tribasic copper chloride versus copper sulfate provided in corn-and molasses-based supplements on forage intake and copper status of beef heifers 2007 · Experiment 1: 100 mg of Cu/d from TBCC · Growing, non-pregnant crossbred beef heifers; 8 per arm | 100 mg | 90 days | 8 |
| Effects of tribasic copper chloride versus copper sulfate provided in corn-and molasses-based supplements on forage intake and copper status of beef heifers 2007 · Experiment 2: 100 mg of Cu/d from CuSO(4) · Growing, non-pregnant crossbred beef heifers; 8 per arm | 100 mg | 90 days | 8 |
| Effects of tribasic copper chloride versus copper sulfate provided in corn-and molasses-based supplements on forage intake and copper status of beef heifers 2007 · Experiment 2: 100 mg of Cu/d from TBCC · Growing, non-pregnant crossbred beef heifers; 8 per arm | 100 mg | 90 days | 8 |
| The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7 2002 · antioxidants and zinc · Adults aged 55–80 years with early-to-late age-related macular degeneration | 2 mg | 5 years | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · Low dietary copper and high-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 1 mg | 90 days | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · High dietary copper and high-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 3 mg | 90 days | — |
| Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial 2008 · verum group · Patients with mild Alzheimer's disease; age and sex not stated | 8 mg | 1 year | — |
| Chaperones CCS, ATOX and COXIV responses to copper supplementation in healthy adults 2012 · supplemented group (SG) · Healthy adults | 8 mg | 60 days | — |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 2 mg | 12 weeks | 202 |
| The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers 2018 · LNS · HIV-infected lactating women in Malawi | 300 mcg | 28 weeks | 185 |
| Mineral status of non-anemic Peruvian infants taking an iron and copper syrup with or without zinc from 6 to 18 months of age: a randomized controlled trial 2013 · iron + copper + zinc group · Non-anemic Peruvian infants randomized at 6 months of age, born at term and weighing more than 2500 g; followed until 18 months | 500 mcg | 1 year | 129 |
| Mineral status of non-anemic Peruvian infants taking an iron and copper syrup with or without zinc from 6 to 18 months of age: a randomized controlled trial 2013 · iron + copper group · Non-anemic Peruvian infants randomized at 6 months of age, born at term and weighing more than 2500 g; followed until 18 months | 500 mcg | 1 year | 122 |
| The effects of a lipid-based nutrient supplement and antiretroviral therapy in a randomized controlled trial on iron, copper, and zinc in milk from HIV-infected Malawian mothers and associations with maternal and infant biomarkers 2018 · ARV + LNS · HIV-infected lactating women in Malawi | 300 mcg | 28 weeks | 90 |
| Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects 2003 · 100 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified | 3 mg | 1 day | 11 |
| Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects 2003 · 400 mg Fe as ferrous gluconate · 11 adults with an ileostomy; mean age 55 ± 9 years; sex not specified | 3 mg | 1 day | 11 |
| Dose-response trial of prophylactic zinc supplements, with or without copper, in young Ecuadorian children at risk of zinc deficiency 2008 · 10 mg Zn + 0.5 mg Cu as copper sulfate · Ecuadorian children aged 12–30 months at baseline with length-for-age z scores below −1.3, at risk of zinc deficiency | 500 mcg | 26 weeks | — |
| Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age 2019 · Fe + MMN · Predominantly anemic, nonpregnant women aged 18–45 years | 2 mg | 12 weeks | 206 |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · Low dietary copper and low-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 1 mg | 90 days | — |
| A moderately high intake compared to a low intake of zinc depresses magnesium balance and alters indices of bone turnover in postmenopausal women 2004 · High dietary copper and low-zinc period · Postmenopausal women, mean age 64.9 years; no other condition stated | 3 mg | 90 days | — |
| Lutein Complex Supplementation Increases Ocular Blood Flow Biomarkers in Healthy Subjects 2019 · lutein phytochemicals complex · Healthy women, mean age 36.8 ± 12.1 years | 2 mg | 3 weeks | 16 |
| Prophylactic iron supplementation in pregnant women in Norway 2001 · 15 mg iron daily · Non-anaemic pregnant women, allocated at about 10 weeks of pregnancy | 2 mg | — | — |
| Some magnesium status indicators and oxidative metabolism responses to low-dietary magnesium are affected by dietary copper in postmenopausal women 2003 · 3.0 mg Cu and 399 mg Mg diet · Postmenopausal women aged 47–78 years | 3 mg | 81 days | 10 |
| Some magnesium status indicators and oxidative metabolism responses to low-dietary magnesium are affected by dietary copper in postmenopausal women 2003 · 1.0 mg Cu and 399 mg Mg diet · Postmenopausal women aged 47–78 years | 1 mg | 81 days | 9 |